Streetbeat News

Stock Prices

ADCT

ADC Therapeutics (NYSE:ADCT) reported a Q4 adjusted EPS of $(0.97), missing the consensus estimate of $(0.50) by 94%. Year-over-year, this represents a 1112.5% decrease in EPS. However, Q4 sales of $16.79M exceeded expectations by 9.52%, despite being 75.94% lower than the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:02 am

ZIM

ZIM Integrated Shipping reported Q4 losses of $(1.23) per share, beating the $(1.29) estimate but marking a 135.76% decrease from last year's earnings. Sales were $1.21B, missing the $1.28B estimate and showing a 44.95% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:02 am

ADM

ADM has entered into a $1 billion accelerated share repurchase agreement, signaling a strong financial position and a commitment to returning value to shareholders. This move is likely to positively impact ADM's stock price in the short term as it reflects confidence in the company's future performance and profitability.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 11:02 am

DLTR

LEN

QQQ

S

SPY

TSLA

WSM

US stock futures indicate a flat open after a relief rally, with caution prevailing on Wall Street. Bitcoin surpasses $73K, while gold declines. Analysts stress the need for robust earnings to justify market strength, highlighting high S&P 500 valuations in a higher interest rate environment. SPDR S&P 500 ETF Trust (SPY) and Invesco QQQ ETF (QQQ) show slight premarket movements. Tesla, Dollar Tree, Williams-Sonoma, SentinelOne, and Lennar are in focus due to stock performance and upcoming earnings.

Portfolio Pulse from Shanthi Rexaline

March 13, 2024 | 10:49 am

DLTR

Dollar Tree projects Q1 net sales to be between $7.6B and $7.9B, compared to the estimated $7.68B. The company also forecasts Q1 earnings per share (EPS) to be in the range of $1.33 to $1.48, which is below the estimated $1.69.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:37 am

DLTR

Dollar Tree projects its FY24 net sales to be between $31 billion and $32 billion, surpassing the estimated $30.66 billion. Additionally, the company forecasts its FY24 EPS to range from $6.70 to $7.30, exceeding the estimated $5.96.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:35 am

DLTR

Dollar Tree Enterprise reported a 3.0% increase in same-store net sales, indicating a positive performance in its retail operations.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:33 am

KSS

Goldman Sachs analyst Brooke Roach has maintained a Sell rating on Kohl's (NYSE:KSS) and kept the price target at $20. This reaffirms Goldman Sachs' bearish stance on the retail company.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 10:24 am

HCM

MXCT

SIGA

SKIN

Beauty Health reported better-than-expected Q4 revenue, leading to a 17.3% pre-market stock increase. Other stocks like HUTCHMED, SIGA Technologies, BeiGene, MaxCyte, Full Truck Alliance, Legend Biotech, Clover Health, and United Natural Foods also saw pre-market gains following positive financial results, analyst ratings, and corporate announcements.

Portfolio Pulse from Avi Kapoor

March 13, 2024 | 10:16 am

LQDA

iShares $ Corp Bond UCITS ETF (NASDAQ:LQDA) reported Q4 earnings with an EPS of $-0.42, missing estimates by -83.0% and a revenue decrease of $829 thousand from the previous year. The ETF has a history of missing EPS estimates, which previously led to a 4.0% share price drop.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 10:15 am